Vitamin E Acetate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00163 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 69 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | inborn disorder of bilirubin metabolism | KG + DL |
| 2 | bilirubin metabolism disease | KG + DL |
| 3 | hereditary North American Indian childhood cirrhosis | KG + DL |
| 4 | drug-induced liver injury | KG + DL |
| 5 | microvillus inclusion disease | KG + DL |
| 6 | hyperbiliverdinemia | KG + DL |
| 7 | Navajo neurohepatopathy | KG + DL |
| 8 | nevus of Ito | KG + DL |
| 9 | adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency | KG + DL |
| 10 | mitochondrial DNA depletion syndrome, hepatocerebral form | KG + DL |
| 11 | chromosome 17q12 deletion syndrome | KG + DL |
| 12 | gracile syndrome | KG + DL |
| 13 | hyperlipidemia | KG + DL |
| 14 | primary release disorder of platelets | KG + DL |
| 15 | glycogen storage disease | KG + DL |
| 16 | non-syndromic visceral malformation | KG + DL |
| 17 | biliary atresia intrahepatic | KG + DL |
| 18 | hypoalphalipoproteinemia | KG + DL |
| 19 | Mirizzi syndrome | KG + DL |
| 20 | pseudo-von Willebrand disease | KG + DL |
| 21 | tricarboxylic acid cycle disorder | KG + DL |
| 22 | disease of transporter activity | KG + DL |
| 23 | pyruvate metabolism disorder | KG + DL |
| 24 | inborn disorder of fatty acid oxidation and ketone body metabolism | KG + DL |
| 25 | adult polyglucosan body disease | KG + DL |
| 26 | Norum disease | KG + DL |
| 27 | glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form | KG + DL |
| 28 | glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form | KG + DL |
| 29 | glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form | KG + DL |
| 30 | glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form | KG + DL |
| 31 | glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form | KG + DL |
| 32 | glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form | KG + DL |
| 33 | glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form | KG + DL |
| 34 | Glanzmann thrombasthenia | KG + DL |
| 35 | renal tubular acidosis | KG + DL |
| 36 | familial hypobetalipoproteinemia | KG + DL |
| 37 | hemolytic anemia due to diphosphoglycerate mutase deficiency | KG + DL |
| 38 | glycogen storage disease due to phosphoglycerate kinase 1 deficiency | KG + DL |
| 39 | transient neonatal thrombocytopenia | KG + DL |
| 40 | dense granule disease | KG + DL |
| 41 | marcothrombocytopenia with mitral valve insufficiency | KG + DL |
| 42 | familial hyperlipidemia | KG + DL |
| 43 | hereditary thrombocytopenia with normal platelets | KG + DL |
| 44 | hypolipoproteinemia (disease) | KG + DL |
| 45 | mitochondrial complex III deficiency nuclear | KG + DL |
| 46 | glycogen storage disease due to glucose-6-phosphatase deficiency | KG + DL |
| 47 | platelet storage pool deficiency | KG + DL |
| 48 | cold agglutinin disease | KG + DL |
| 49 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 50 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
(Showing top 50 of 69 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.